These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29120250)

  • 21. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
    Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.
    Almeida DR; Khan Z; Xing L; Bakar SN; Rahim K; Urton T; El-Defrawy SR
    J Cataract Refract Surg; 2012 Sep; 38(9):1537-43. PubMed ID: 22795976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery.
    Zaczek A; Artzen D; Laurell CG; Stenevi U; Montan P
    J Cataract Refract Surg; 2014 Sep; 40(9):1498-505. PubMed ID: 25135542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical non-steroidal anti-inflammatory drugs for the treatment of cystoid macular edema post Descemet's stripping automated endothelial keratoplasty.
    Kitazawa K; Kayukawa K; Wakimasu K; Inatomi T; Hieda O; Mori K; Sotozono C; Kinoshita S
    Jpn J Ophthalmol; 2018 Nov; 62(6):615-620. PubMed ID: 30255396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.
    Kern TS; Miller CM; Du Y; Zheng L; Mohr S; Ball SL; Kim M; Jamison JA; Bingaman DP
    Diabetes; 2007 Feb; 56(2):373-9. PubMed ID: 17259381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Macular edema after prior brachytherapy in a diabetic retinopathy patient (clinical case)].
    Ignat'ev SA; Steshenko ON; Khionidi YN
    Vestn Oftalmol; 2016; 132(5):68-71. PubMed ID: 27911428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema.
    Vinten M; Larsen M; Lund-Andersen H; Sander B; La Cour M
    Acta Ophthalmol Scand; 2007 Feb; 85(1):21-6. PubMed ID: 17244205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of nepafenac on the foveal profile of glaucomatous patients undergoing phacoemulsification.
    Milla E; Stirbu O; Franco IJ; Hernández SJG; Rios J; Duch S
    Int Ophthalmol; 2017 Oct; 37(5):1147-1153. PubMed ID: 27771823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of addition of nepafenac 0.1% to steroid eye drops in prevention of post-phaco macular edema in high-risk eyes.
    El Gharbawy SA; Darwish EA; Abu Eleinen KG; Osman MH
    Eur J Ophthalmol; 2019 Jul; 29(4):453-457. PubMed ID: 30203671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of intravitreal ranibizumab on the ocular circulation of the untreated fellow eye.
    Sugimoto M; Nunome T; Sakamoto R; Kobayashi M; Kondo M
    Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1543-1550. PubMed ID: 28656342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema.
    Alkuraya H; Kangave D; Abu El-Asrar AM
    Int Ophthalmol; 2005 Jun; 26(3):93-9. PubMed ID: 17063373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EVALUATION OF THE EFFECT OF TOPICAL INTERFERON α2b AS A COMPLEMENTARY TREATMENT OF MACULAR EDEMA OF PATIENTS WITH DIABETIC RETINOPATHY: A Double-Blind Placebo-Controlled Randomized Clinical Trial Study.
    Afarid M; Meshksar A; Salehi A; Safarpour MM
    Retina; 2020 May; 40(5):936-942. PubMed ID: 30839494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of preoperative topical nepafenac 0.1% on inflammatory response after uncomplicated cataract surgery in healthy subjects.
    Cagini C; Cerquaglia A; Pellegrino A; Iannone A; Lupidi M; Fiore T
    Acta Ophthalmol; 2021 Feb; 99(1):e70-e73. PubMed ID: 32558305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy.
    Pollack A; Staurenghi G; Sager D; Mukesh B; Reiser H; Singh RP
    Br J Ophthalmol; 2017 Apr; 101(4):423-427. PubMed ID: 27388251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HYPERREFLECTIVE RETINAL SPOTS AND VISUAL FUNCTION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN CENTER-INVOLVING DIABETIC MACULAR EDEMA.
    Vujosevic S; Berton M; Bini S; Casciano M; Cavarzeran F; Midena E
    Retina; 2016 Jul; 36(7):1298-308. PubMed ID: 26689274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical dexamethasone-cyclodextrin microparticle eye drops for diabetic macular edema.
    Tanito M; Hara K; Takai Y; Matsuoka Y; Nishimura N; Jansook P; Loftsson T; Stefánsson E; Ohira A
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):7944-8. PubMed ID: 21896859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective, Randomized Study Comparing the Effect of 0.1% Nepafenac and 0.4% Ketorolac Tromethamine on Macular Thickness in Cataract Surgery Patients With Low Risk for Cystoid Macular Edema.
    Ramakrishnan S; Baskaran P; Talwar B; Venkatesh R
    Asia Pac J Ophthalmol (Phila); 2015; 4(4):216-20. PubMed ID: 26225780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema.
    Soliman W; Vinten M; Sander B; Soliman KA; Yehya S; Rahman MS; Larsen M
    Acta Ophthalmol; 2008 Jun; 86(4):365-71. PubMed ID: 18028237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.
    ; Fong DS; Strauber SF; Aiello LP; Beck RW; Callanan DG; Danis RP; Davis MD; Feman SS; Ferris F; Friedman SM; Garcia CA; Glassman AR; Han DP; Le D; Kollman C; Lauer AK; Recchia FM; Solomon SD
    Arch Ophthalmol; 2007 Apr; 125(4):469-80. PubMed ID: 17420366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.